These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Gazelle GS; McMahon PM; Beinfeld MT; Halpern EF; Weinstein MC Radiology; 2004 Dec; 233(3):729-39. PubMed ID: 15564408 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Abramson RG; Rosen MP; Perry LJ; Brophy DP; Raeburn SL; Stuart KE Radiology; 2000 Aug; 216(2):485-91. PubMed ID: 10924575 [TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Compared With Radiofrequency Ablation for Inoperable Colorectal Liver Metastases. Kim H; Gill B; Beriwal S; Huq MS; Roberts MS; Smith KJ Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1175-83. PubMed ID: 27130789 [TBL] [Abstract][Full Text] [Related]
5. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. Schindera ST; Nelson RC; DeLong DM; Clary B J Vasc Interv Radiol; 2006 Oct; 17(10):1631-7. PubMed ID: 17057005 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669 [TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias. Kertes PJ; Kalman JM; Tonkin AM Aust N Z J Med; 1993 Aug; 23(4):433-6. PubMed ID: 8240167 [TBL] [Abstract][Full Text] [Related]
8. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986 [TBL] [Abstract][Full Text] [Related]
10. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902 [TBL] [Abstract][Full Text] [Related]
12. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781 [TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of navigated radiofrequency ablation for hepatocellular carcinoma in China. Lai Y; Li K; Li J; Liu SX Int J Technol Assess Health Care; 2014 Oct; 30(4):400-8. PubMed ID: 25682956 [TBL] [Abstract][Full Text] [Related]
14. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740 [TBL] [Abstract][Full Text] [Related]
15. Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Beard SM; Holmes M; Price C; Majeed AW Ann Surg; 2000 Dec; 232(6):763-76. PubMed ID: 11088071 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338 [TBL] [Abstract][Full Text] [Related]
17. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more? Alexander ES; Machan JT; Ng T; Breen LD; DiPetrillo TA; Dupuy DE J Vasc Interv Radiol; 2013 Apr; 24(4):476-82. PubMed ID: 23462066 [TBL] [Abstract][Full Text] [Related]
18. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results. Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241 [TBL] [Abstract][Full Text] [Related]